Molecular Carcinogenesis

Papers
(The median citation count of Molecular Carcinogenesis is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
42
Issue Information ‐ Ed Board41
Cover Image, Volume 62, Issue 440
The Parkinson's disease‐associated protein α‐synuclein inhibits hepatoma by exosome delivery37
Combined Inhibition of XPO1 and DNA Methylation Exerts Synergistic Effects in DLBCL33
Forkhead Box Q1 is a novel regulator of autophagy in breast cancer cells32
Inhibition of the RBMS1/PRNP axis improves ferroptosis resistance‐mediated oxaliplatin chemoresistance in colorectal cancer31
Potentiated effects of lactate receptor GPR81 on immune microenvironment in breast cancer28
UBE2D1 promotes glioblastoma proliferation by modulating p21 ubiquitination27
RELA promotes the progression of oral squamous cell carcinoma via TFAP2A‐Wnt/β‐catenin signaling26
Risk SNP‐mediated LINC01614 upregulation drives head and neck squamous cell carcinoma progression via PI3K/AKT signaling pathway23
HNRNPC promotes estrogen receptor‐positive breast cancer cell cycle by stabilizing WDR77 mRNA in an m6A‐dependent manner23
Predictive Value of Neutrophil Extracellular Traps in Neoadjuvant Chemotherapy for Muscle‐Invasive Bladder Cancer22
IRF2BP2 drives lymphatic metastasis in OSCC cells by elevating mitochondrial fission‐dependent fatty acid oxidation22
SIRT1 promotes doxorubicin‐induced breast cancer drug resistance and tumor angiogenesis via regulating GSH‐mediated redox homeostasis22
Delta‐Like Homolog 2 Facilitates Malignancy of Hepatocellular Carcinoma via Activating EGFR/PKM2 Signaling Pathway22
The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway21
CRISPR‐Based Gene Dependency Screens Reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid Cancer21
PTPN2 Expression in Hypopharyngeal Squamous Cell Carcinoma and Its Clinical Significance21
Histone lactylation facilitates hepatocellular carcinoma progression by upregulating endothelial cell‐specific molecule 1 expression20
Issue Information ‐ Ed Board20
19
19
Issue Information ‐ Ed Board19
Loss of CBX2 causes genomic instability and Wnt activation in high grade serous ovarian carcinoma cells18
18
Venetoclax Synergizes With Regorafenib for Colorectal Cancer by Targeting BCL‐218
Identification of concurrent STAT3::RARA and RARA::STAT5b fusions in a variant APL case17
Hepatitis B Virus X Protein Contributes to Hepatocellular Carcinoma via Upregulation of KIAA1429 Methyltransferase and mRNA m6A Hypermethylation of HSPG2/Perlecan17
Oncogenic fusion of CD63‐BCAR4 contributes cancer stem cell‐like properties via ALDH1 activity17
AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP/SLC7A11 signaling pathway16
VPS45 Contributes to the Progression of Hepatocellular Carcinoma by Triggering the Wnt/β‐Catenin Signaling Pathway16
YTHDF1 enhances stemness and chemoresistance in triple‐negative breast cancer cells by upregulating SIAH216
16
Homologous recombination repair gene mutations in colorectal cancer favors treatment of immune checkpoint inhibitors16
Blocking the ATR‐SerRS‐VEGFA pathway targets angiogenesis for UV‐induced cutaneous squamous cell carcinoma16
15
HORMAD1 Polymorphisms Influence Susceptibility to Esophageal Squamous Cell Carcinoma Through Gene–Smoking Interaction15
Circ_0007429/miR‐637/TRIM71/Ago2 axis participates in the regulation of proliferation, migration, invasion, apoptosis, and aerobic glycolysis of HCC15
Atypical BCR‐ABL1 transcript in mixed phenotype acute leukemia with bone marrow necrosis15
15
DNTT activation, TdT‐aided gene length mutation, and better prognosis in ATG‐based regimen allo‐HSCT in AML15
Transmembrane protein 147, as a potential Sorafenib target, could expedite cell cycle process and confer adverse prognosis in hepatocellular carcinoma15
ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β‐catenin pathway15
Identification of a Novel RUNX1::HMGN1 Fusion in Therapy Acute Myeloid Leukemia15
Correction to “Cucurbitacin B Induces Inhibitory Effects via CIP2A/PP2A/Akt Pathway in Glioblastoma Multiforme”15
High‐Fat Diet Promotes Glycolysis in Hepatocellular Carcinoma by Suppressing Hepatic Kisspeptin Signaling in Mice15
β‐Elemene Inhibits Adrenocortical Carcinoma Cell Proliferation and Migration, and Induces Apoptosis by Up‐Regulating miR‐486‐3p/Targeting NPTX1 Axis15
Tissue‐of‐origin for cancers determines HIF‐1 activation induced phenotypic heterogeneity14
A‐to‐I‐Edited miR‐1304‐3p Inhibits Glycolysis and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inactivating Wnt5a/ROR2 Signaling14
M2 macrophage exosome‐derived Apoc1 promotes ferroptosis resistance in osteosarcoma by inhibiting ACSF2 deubiquitination14
The 5‐Methylcytosine RNA Modification in Hepatitis B Virus‐Negative Hepatocellular Carcinoma: Insights From Long‐Read Nanopore Sequencing14
Divergence of mutational signatures in association with breast cancer subtype14
Levels of Bile Acid Metabolism Are Associated With Alterations of Gut Microbes in Hepatocellular Carcinoma14
14
HDAC inhibitor regulates the tumor immune microenvironment via pyroptosis in triple negative breast cancer14
Issue Information ‐ Ed Board14
KNTC1 knockdown inhibits the proliferation and migration of osteosarcoma cells by MCM214
Plakophilin 1 in carcinogenesis14
HMGB3 Contributes to Anti‐PD‐1 Resistance by Inhibiting IFN‐γ‐Driven Ferroptosis in TNBC14
Targeting TROP2 and Exploiting AUNIP as a Determinant of ADC Cytotoxicity and Chemosensitivity in HNSCC and ESCA Cancers13
Upregulation of collagen type X alpha 1 promotes the progress of triple‐negative breast cancer via Wnt/β‐catenin signaling13
SNORD60 promotes the tumorigenesis and progression of endometrial cancer through binding PIK3CA and regulating PI3K/AKT/mTOR signaling pathway13
Potential Crosstalk Between ANXA1+ Epithelial Cells and FABP4+ TAM Cells of Ferroptosis‐Related Molecular Clusters Promotes an Immunosuppressive Microenvironment in Non‐Small Cell Lung Cancer13
Inhibition of Growth and Survival of Head and Neck Cancer Cells by Silibinin Involves the Down‐Regulation of Erk1/2, AKT and STAT3 Signaling13
Issue Information ‐ Ed Board13
CYP4F11, an NRF2 Target Gene, Promotes Hepatocellular Carcinoma Cell Growth13
Doublecortin‐like kinase 1 is a therapeutic target in squamous cell carcinoma13
Predictive significance of PRR11 in prognosis and immune infiltration of glioma patients12
Imatinib Impedes EMT and Notch Signalling by Inhibiting p300 Acetyltransferase in Breast Cancer Cells12
Integrative Bioinformatics Analysis and Experimental Study of NLRP12 Reveal Its Prognostic Value and Potential Functions in Ovarian Cancer12
12
Association of SIRT6 Expression With Risk of Pneumonitis Induced by Radiotherapy in Cancer Patients12
Splicing factor SRSF3 promotes the progression of cervical cancer through regulating DDX512
Genetic variations associated with telomere length predict the risk of recurrence of non‐oropharyngeal head and neck squamous cell carcinoma12
Issue Information ‐ Ed Board12
Energy balance‐related factors in childhood and adolescence and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status12
LATS‐regulated nuclear‐cytoplasmic translocation of SREBP2 inhibits hepatocellular carcinoma cell migration and invasion via epithelial–mesenchymal transition12
12
12
Cover Image, Volume 62, Issue 212
The HDAC2–MTA3 interaction induces nonsmall cell lung cancer cell migration and invasion by targeting c‐Myc and cyclin D111
Regulation of programmed death ligand 1 (PD‐L1) expression by TNF‐related apoptosis‐inducing ligand (TRAIL) in triple‐negative breast cancer cells11
EXPRESSION OF CONCERN: Growth Inhibition of Pancreatic Cancer Cells by Histone Deacetylase Inhibitor Belinostat Through Suppression of Multiple Pathways Including Hif, Nfkb,11
Computed Tomography‐Based Radiomics and Genomics Analyses for Survival Prediction of Stage III Unresectable Non‐Small Cell Lung Cancer Treated With Definitive Chemoradiotherapy and Immunotherapy11
A Combinatorial Model of Serum tsRNAs as a Diagnostic Biomarker for Non‐Small Cell Lung Cancer11
Breast cancer malignancy is governed by regulation of the macroH2A2/TM4SF1 axis, the AKT/NF‐κB pathway, and elevated MMP13 expression11
Evaluation of Epidermal Growth Factor Receptor and Its Inducible Feedback Inhibitor Leucine Rich Repeats and Immunoglobulin Like Domains 1 as Prognostic Marker in Oral Cancer11
Loss of PTPRS elicits potent metastatic capability and resistance to temozolomide in glioblastoma11
A variant in CYP26B1 associated with esophageal squamous cell carcinoma risk by affecting retinoic acid metabolism11
Review: PD‐L1 as an emerging target in the treatment and prevention of keratinocytic skin cancer11
HER3 V104 mutations regulate cell signaling, growth, and drug sensitivity in cancer11
A systems biology‐based approach to screen key splicing factors in hepatocellular carcinoma11
The JAK3Q988P mutation reveals oncogenic potential and resistance to ruxolitinib11
Diosmetin: A dietary flavone as modulator of signaling pathways in cancer progression11
The cumulative antitumor effects of regorafenib and radiotherapy in hepatocellular carcinoma11
Linarin Suppresses the Progression of Colorectal Cancer by Inhibiting the HIF‐1α/PD‐L1 Axis11
Issue Information ‐ Ed Board10
Targeting Hippo/YAP in intrahepatic cholangiocarcinoma: Promising molecules in cancer therapy10
TRIM16 E121D variant affects the risk and prognosis of hepatocellular carcinoma by modulating the Wnt/β‐catenin pathway10
Integrated Analysis Reveals ZNF184 as a Novel Regulator of Stemness‐Associated Paclitaxel Resistance and Tumor Progression in Breast Cancer10
Baicalein promotes KDM4E to induce BICD1 and inhibit triple‐negative breast cancer progression by blocking PAR1 signaling10
10
KCNE3 Facilitates M1 Macrophage Polarization by Suppressing the Wnt/β‐Catenin Pathway, Inhibiting Glioma Proliferation, Migration, and Invasion10
circEIF3I Promotes Colorectal Cancer Metastasis by Regulating the miR‐328‐3p/NCAPH Axis10
Monocarboxylate Transporter‐1 Is Dispensable for Hepatocellular Carcinoma Development10
HIF‐1α regulates the cell viability in radioiodine‐resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2/NF‐κB signaling pathway10
Deciphering CD4+ T cell‐mediated responses against cancer10
BORIS variant SF2(C2/A4) promotes the malignant development of liver cancer by activating epithelial‐mesenchymal transition and hepatic stellate cells10
MicroRNA‐505‐5p/‐3p Regulates the Proliferation, Invasion, Apoptosis, and Temozolomide Resistance in Mesenchymal Glioma Stem Cells by Targeting AUF110
Transcription factor Nrf2 binds to circRNAPIBF1 to regulate SOD2 in lung adenocarcinoma progression10
GRP78 promotes bone metastasis of prostate cancer by regulating bone microenvironment through Sonic hedgehog signaling10
9
Lesser prevalence of polyps/WNT‐dysregulation and concomitant upregulation of gamma‐catenin/MYC point to alternate pathways in colorectal cancer in India9
CDK10 suppresses metastasis of lung adenocarcinoma through inhibition of the ETS2/c‐Raf/p‐MEK/p‐ERK signaling loop9
KDM6A Exhibits Antitumor Activities Toward Ovarian Cancer by Epigenetically Activating Transcription of ISG‐159
Whole‐Genome Bisulfite Sequencing Identifies Blood‐Based DNA Methylation Biomarker for Hepatocellular Carcinoma9
9
Four and a half LIM domains 2 (FHL2) attenuates tumorigenesis of gastrointestinal stromal tumors (GISTs) by negatively regulating KIT signaling9
Corrigendum9
NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m5C‐dependent manner9
circPPP2R4 promotes colorectal cancer progression and reduces ROS production through the miR‐646/FOXK1 axis9
KIF4A promotes genomic stability and progression of endometrial cancer through regulation of TPX2 protein degradation9
Triiodothyronine (T3) suppresses hepatic tumorigenesis and development by inhibiting the phosphorylation of ERK9
GRPEL2 Modulates Apoptosis in Esophageal Squamous Cell Carcinoma via the JNK Signaling Pathway9
AN02, a Naovel Curcumin Derivative, Orchestrates APC‐SMAD4‐Mediated CTLA‐4 Degradation for Ovarian Cancer Therapy9
Associations of mitochondrial DNA copy number with incident risks of gastrointestinal cancers: A prospective case–cohort study9
Dysregulated BCL9 Controls Tumorigenicity and Ferroptosis Susceptibility by Binding With Nrf2 in Thyroid Carcinoma9
Sulforaphane impaired immune checkpoint blockade therapy through activating ΔNP63α/PD‐L1 axis in gastric cancer9
NSUN2 Promotes Prostate Cancer Cell Proliferation and Migration Through m5C Modifications of YES19
γ‐Tocotrienol enhances autophagy of gastric cancer cells by the regulation of GSK3β/β‐Catenin pathway8
Metabolism‐focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer8
RUNX1 Directly Activates WNT2 to Orchestrate Tumor‐Associated Macrophage Reprogramming in Colorectal Cancer8
Tex10 interacts with STAT3 to regulate hepatocellular carcinoma growth and metastasis8
Liquiritin Enhances Chemosensitivity to Doxorubicin in Breast Cancer by Promoting Ubiquitination‐Mediated Degradation of MCL18
Characterizing Genetic Susceptibility to Colorectal Cancer in Taiwan Through Genome‐Wide Association Study8
Corrigendum8
ACKR3 orchestrates Hedgehog signaling to promote renal cell carcinoma progression8
Alkaliptosis induction counteracts paclitaxel‐resistant ovarian cancer cells via ATP6V0D1‐mediated ABCB1 inhibition8
SRPK1 Activation Facilitates Gli3S664 Phosphorylation and Promotes Metastasis in Esophageal Squamous Cell Carcinoma8
Harnessing Cuproptosis for Antitumor Immunity: A Review of Current Evidence and Therapeutic Strategies8
Regulation of SELENOF translation by eIF4a3: Possible role in prostate cancer progression8
Dihydroartemisinin synergistically enhances the cytotoxic effects of oxaliplatin in colon cancer by targeting the PHB2‐RCHY1 mediated signaling pathway8
Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma8
TMED3 stabilizes SMAD2 by counteracting NEDD4‐mediated ubiquitination to promote ovarian cancer8
ZNF480 Accelerates Chemotherapy Resistance in Breast Cancer by Competing With TRIM28 and Stabilizing LSD1 to Upregulate the AKT‐GSK3β‐Snail Pathway8
CD137 Protein Expression Pattern Determines the Functional Role of Galectin‐9 in Colorectal Cancer8
HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway8
Withaferin A mediated changes of miRNA expression in breast cancer‐derived mammospheres8
LUCAT1 Mediates MYC‐Targeted Suppression of Squamous Cell Carcinoma8
ATP citrate lyase promotes the progression of hepatocellular carcinoma by activating the REGγ‐proteasome pathway8
8
Adipocytes Promote Endometrial Cancer Progression Through Activation of the SIRT1‐HMMR Signaling Axis7
Daurisoline suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting MEK1/2 kinase7
FAPhigh α‐SMAlow cancer‐associated fibroblast‐derived SLPI protein encapsulated in extracellular vesicles promotes ovarian cancer development via activation of PI3K/AKT and downs7
Identification of Plasma rRNA‐Derived Small RNA Biomarkers for Diagnosis of Colorectal Cancer7
7
Cover Image, Volume 63, Issue 57
PKMYT1 induced by YAP/TEAD1 gives rise to the progression and worse prognosis of bladder cancer7
Loss of SETD2‐mediated downregulation of intracellular and exosomal miRNA‐10b determines MAPK pathway activation and multidrug resistance in renal cancer7
TRAF6 Exerts Tumor‐Promoting Effects via Genetic and Autophagic Modulation in Gastric Cancer7
Hypoxia Promotes Malignant Progression of Colorectal Cancer by Inducing POSTN+ Cancer‐Associated Fibroblast Formation7
7
Issue Information ‐ Ed Board7
KIN17 promotes cell migration and invasion through stimulating the TGF‐β/Smad2 pathway in hepatocellular carcinoma7
7
Pregnane X Receptor Activation Induces Ferroptosis Resistance Through Upregulation of FSP17
FAP positive cancer‐associated fibroblasts promote tumor progression and radioresistance in esophageal squamous cell carcinoma by transferring exosomal lncRNA AFAP1‐AS17
Molecular Analysis of Genes CEBPA, NPM1, IDH1, and RUNX1 Polymorphisms as Biomarker Potential in Leukemia Patients7
RETRACTION: Arsenic Exposure Through Drinking Water Leads to Senescence and Alteration of Telomere Length in Humans: A Case‐Control Study in West Bengal, India7
Issue Information ‐ Ed Board7
Expression of Concern: Amplification of Cyclinl1 in Uterine Cervical Carcinoma Has Prognostic Implications7
BATF promotes extramedullary infiltration through TGF‐β1/Smad/MMPs axis in acute myeloid leukemia7
Mass cytometry and transcriptomic profiling reveal PD1 blockade induced alterations in oral carcinogenesis7
KLHDC7B as a novel diagnostic biomarker in urine exosomal mRNA promotes bladder urothelial carcinoma cell proliferation and migration, inhibits apoptosis7
CircDUSP1 regulates tumor growth, metastasis, and paclitaxel sensitivity in triple‐negative breast cancer by targeting miR‐761/DACT2 signaling axis7
G2 and S phase‐expressed‐1 induces chromosomal instability in esophageal squamous cell carcinoma cells and inhibits cell apoptosis through ROS/JNK signaling7
The serine protease CORIN promotes progression of gastric cancer by mediating the ERK1/2 MAPK pathway7
Precision therapy for cancer prevention by targeting carcinogenesis7
The efficacy and safety of pH‐responsive and photothermal‐sensitive multifunctional nanoparticles loaded with cryptotanshinone for the treatment of gastric cancer7
microRNA‐2117 Negatively Regulates Liver Cancer Stem Cells Expansion and Chemoresistance Via Targeting SOX27
CNOT4 suppresses nonsmall cell lung cancer progression by promoting the degradation of PAF17
Drug‐target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk7
Issue Information ‐ Ed Board7
Issue Information ‐ Ed Board7
Elucidating the Mechanism of 1,4,5,6,7,8‐Hexahydropyrido[4,3‐d]Pyrimidine‐Induced Inhibition of Glioma Growth Through miR‐873‐3p7
Tumor‐derived extracellular vesicles confer 5‐fluorouracil resistance in esophageal cancer via long noncoding RNA AC116025.2 delivery7
JD‐02, a novel Hsp90 inhibitor, induces ROS/SRC axis‐dependent cytoprotective autophagy in colorectal cancer cells7
A systems biology approach and in vitro experiment indicated Rapamycin targets key cancer and cell cycle‐related genes and miRNAs in triple‐negative breast cancer cells7
Spatial Transcriptomic Landscape of Canine Oral Squamous Cell Carcinoma7
LINC02562 Promotes Progression of Lung Cancer by Regulating NTHL1 Dependent DNA Damage Repair Mechanisms6
Zinc Finger Protein 263 Augments Autophagy and Promotes Intrahepatic Cholangiocarcinoma Proliferation6
P21‐Activated Kinase 1 (PAK1) Modulates Therapeutic Response to Ionizing Radiation in Head and Neck Squamous Cell Carcinoma Cells6
A comprehensive evaluation of serum tRF‐29‐R9J8909NF5JP as a novel diagnostic and prognostic biomarker for gastric cancer6
6
Evaluation and Comparison of Prognostic Multigene Tests in Early‐Stage Breast Cancer: Which Is the Most Effective? A Literature Review Exploring Clinical Utility to Enhance Therapeutic Management in L6
Issue Information ‐ Ed Board6
Corrigendum6
Downregulation of cellular retinoic acid binding protein 1 fosters epithelial–mesenchymal transition in thyroid cancer6
Radiotherapy and Immune System Interactions Historical Perspectives and Clinical Advancements6
Integrated analysis of single cell and bulk RNA sequencing identifies CTHRC1+INHBA+CAF as drivers of colorectal cancer progression6
RNF7‐Mediated ROS Targets Malignant Phenotype and Radiotherapy Sensitivity in Glioma With Different IDH1 Genotypes6
MAZ Coordinates With HDAC1 to Promote Hepatocarcinoma Proliferation and Metastasis Through Transcriptional Repression of CSK6
Causal Relationship Between Blood Metabolites and Prostate Cancer Risk: A Two‐Sample Mendelian Randomization Study6
SLC5A6 Regulates Lipid Metabolism and Lymph Node Metastasis in Cervical Cancer via FASN6
Effect of CHRDL1 on angiogenesis and metastasis of colorectal cancer cells via TGF‐β/VEGF pathway6
Integrated Genomics Reveal Potential Resistance Mechanisms of PANoptosis‐Associated Genes in Acute Myeloid Leukemia6
KIF4A Inhibits Ferroptosis in Glioblastoma via the CHMP4B/GPX4 Axis and Promotes Temozolomide Resistance6
Inhibition of endogenous hydrogen sulfide production suppresses the growth of nasopharyngeal carcinoma cells6
PDZ‐binding kinase aggravates pancreatic neuroendocrine neoplasm progression by activating the AKT/mTOR pathway6
ARMC10 Drives Glioblastoma Progression Through Activating Notch Pathway6
6
circSLC25A13 acts as a ceRNA to regulate AML progression via miR‐616‐3p/ADCY2 axis6
Expression of Concern: Alterations of RASSF1A in Premalignant Cervical Lesions: Clinical and Prognostic Significance6
6
Withaferin A Exerts Cytotoxicity in Single/Multidrug‐Resistant Gastric and Ovarian Cancer Cells and Tumor Xenografts Through the AKT–NF‐κB–STAT3–Survivin Axis6
Uncovering the Role of DNA Repair Impairment in UVA‐Induced Mutagenesis in Human Xeroderma Pigmentosum Variant Cells6
Glutamine, Serine and Glycine at Increasing Concentrations Regulate Cisplatin Sensitivity in Gastric Cancer by Posttranslational Modifications of KDM4A6
ZMYM4 Acts as a Potential Prognostic Biomarker and Promotes the Malignant Progression of Hepatocellular Carcinoma Cells: It Is Regulated by miR‐34a‐5p6
6
Issue Information ‐ Ed Board6
EphA2/SHP2/SOX8 Axis: A Novel Target for Regulation of Migration and Cetuximab Treatment Sensitivity in Oral Squamous Cell Carcinoma5
Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR‐1343‐3p/Bcl‐3 axis through TGFβ/Smad3/EMT signaling5
CDK4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomas5
Overexpression of TYRO3 indicates poor prognosis and induces gastric cancer progression via AKT‐mTOR pathway5
PKP2 induced by YAP/TEAD4 promotes malignant progression of gastric cancer5
Heterochiral dipeptide d‐phenylalanyl‐l‐phenylalanine (H‐DPhe‐LPhe‐OH) as a potential inducer of metastatic suppressor NM23H1 in p53 wild‐type and mutant ce5
USP15 Promotes Pancreatic Cancer Progression and Cisplatin Resistance By Activating DNA Damage Repair5
LncRNA FGD5‐AS1 Facilitates Hepatocellular Carcinoma Cell Stemness by Enhancing PKD1 mRNA Stability Through Binding With MSI25
5
Venetoclax overcomes resistance to all‐trans retinoic acid in a variant acute promyelocytic leukemia with TNRC18::RARA fusion5
Tectoridin inhibits the growth of bladder cancer by regulating PI3K/MAPK pathway through RAB27B5
Issue Information ‐ Ed Board5
GBP2 serves as a novel prognostic biomarker and potential immune microenvironment indicator in renal cell carcinoma5
Issue Information ‐ Ed Board5
Case report & review: Bilateral NIFTP harboring concomitant HRAS and KRAS mutation: Report of an unusual case and literature review5
Issue Information ‐ Ed Board5
BTG1 Acts as a Critical Tumor Suppressor Link Between HDAC Inhibition and β‐Catenin Signaling Suppression in Diffuse Large B‐Cell Lymphoma5
Cover Image, Volume 61, Issue 75
Issue Information ‐ Ed Board5
Wogonin Inhibits Ovarian Cancer by Activating the AMPK‐TET2‐5hmC Axis5
DSN1 Interaction With Centromere‐Associated Proteins Promotes Chromosomal Instability in Hepatocellular Carcinoma5
RETRACTION: “ LncAPC Drives Wnt/Β‐Catenin Activation and Liver TIC Self‐Renewal Through EZH2 Mediated APC Transcriptional Inhibition”5
Prevalence of Molecular Subtypes of Gastric Cancer in Taiwan and the Impact of High SLC25A22 Expression on Survival: A Single‐Center Experience5
Phosphoproteomics of extracellular vesicles integrated with multiomics analysis reveals novel kinase networks for lung cancer5
Identification of Interleukin‐Related Genes Signature for Prognosis Prediction in Head and Neck Squamous Cell Carcinoma Patients5
GOLPH3 promotes tumor malignancy via inhibition of ferroptosis by upregulating SLC7A11 in cholangiocarcinoma5
5
Valproic acid increased the efficacy of EGFR TKIs on EGFR/TP53 co‐mutated lung cancers and downregulated mutant‐p53 levels5
5
0.047222852706909